CERo Therapeutics Holdings, Inc. (CERO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 1.16M | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | -100% | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 276.14K | 276.14K | 272.77K | 267.66K | 269.48K | 581.41K | 297.34K | 293.25K | 288.16K | 284.75K | 281.41K | 0 |
| COGS % of Revenue | - | - | - | - | - | 50% | - | - | - | - | - | - |
| Gross Profit | -276.14K | -276.14K | -272.77K | -267.66K | -269.48K | 581.41K | -297.34K | -293.25K | -288.16K | -284.75K | -281.41K | 0 |
| Gross Margin % | - | - | - | - | - | 50% | - | - | - | - | - | - |
| Gross Profit Growth % | -2.47% | -147.49% | 8.26% | 8.73% | 6.48% | 304.18% | -5.66% | - | - | - | - | - |
| Operating Expenses | 4.57M | 4.15M | 4.09M | 4.72M | 4.95M | 2.38M | 4.4M | 5.15M | 4.26M | 836.42K | 1.54M | 1.54M |
| OpEx % of Revenue | - | - | - | - | - | 204.99% | - | - | - | - | - | - |
| Selling, General & Admin | 2.51M | 1.23M | 1.98M | 2.68M | 2.2M | 1.17M | 2.63M | 2.43M | 3.29M | 374.59K | 258.01K | 1.52M |
| SG&A % of Revenue | - | - | - | - | - | 100.83% | - | - | - | - | - | - |
| Research & Development | 2.34M | 2.33M | 2.39M | 2.75M | 2.91M | 1.21M | 1.77M | 2.71M | 1.38M | 733.36K | 1.28M | 1.19M |
| R&D % of Revenue | - | - | - | - | - | 104.16% | - | - | - | - | - | - |
| Other Operating Expenses | -276.14K | 587.41K | -272.77K | -707.3K | -156.25K | 0 | 0 | 0 | -403.89K | -271.52K | 0 | -22.7K |
| Operating Income | -4.85M | -4.43M | -4.36M | -4.72M | -4.95M | -1.2M | -4.4M | -5.15M | -4.55M | -369.34K | -429.8K | -1.54M |
| Operating Margin % | - | - | - | - | - | -103.06% | - | - | - | - | - | - |
| Operating Income Growth % | 2.12% | -269.36% | 0.9% | 8.24% | -8.75% | -224.46% | -924.25% | -233.53% | -671.18% | 71.31% | 48.63% | -309.89% |
| EBITDA | -4.85M | -4.15M | -4.09M | -4.46M | -4.68M | -913.73K | -4.4M | -5.03M | -4.26M | -84.59K | 1 | -1.27M |
| EBITDA Margin % | - | - | - | - | - | -78.58% | - | - | - | - | - | - |
| EBITDA Growth % | -3.52% | -354.19% | 7.1% | 11.48% | -9.78% | -980.23% | -99999900% | -297.58% | -1246.42% | -8458600% | -80% | -236.22% |
| D&A (Non-Cash Add-back) | 0 | 276.14K | 272.77K | 267.66K | 269.48K | 284.63K | 0 | 114.3K | 288.16K | 284.75K | 429.8K | 277.45K |
| EBIT | -4.85M | -4.43M | -4.36M | -5.43M | -5.11M | 1.26M | -4.4M | -2.43M | -2.29M | -1.27M | -429.8K | -2.41M |
| Net Interest Income | -163.14K | -8.95K | 5.94K | 13.78K | 850 | 12.56K | 4.42K | -16.98K | -9.63K | 20.09K | 157 | 59.42K |
| Interest Income | 3.15K | -8.95K | 5.94K | 13.78K | 850 | -4.42K | 4.42K | 0 | 0 | 20.09K | 157 | 59.42K |
| Interest Expense | 166.29K | 0 | 0 | 0 | 0 | -26.61K | 0 | 16.98K | 9.63K | 0 | 0 | 0 |
| Other Income/Expense | -1.04M | -114.37K | -493.82K | -693.52K | -155.4K | 2.44M | 174.27K | 2.7M | 2.25M | 110.99K | 186.22K | 321.24K |
| Pretax Income | -5.89M | -4.54M | -4.86M | -5.42M | -5.11M | 1.24M | -4.23M | -2.45M | -2.3M | -258.35K | -308.28K | -1.39M |
| Pretax Margin % | - | - | - | - | - | 106.99% | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.41K | 25.75K | 44.66K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -9.45% | -8.35% | -3.21% |
| Net Income | -5.89M | -4.54M | -4.86M | -5.42M | -5.11M | 1.24M | -4.23M | -2.45M | -2.3M | -282.76K | -334.03K | -2.09M |
| Net Margin % | - | - | - | - | - | 107.01% | - | - | - | - | - | - |
| Net Income Growth % | -15.28% | -464.91% | -14.86% | -121.24% | -122.03% | 540.06% | -1165.75% | -16.99% | 5.67% | -7.65% | -495.28% | -1775.97% |
| Net Income (Continuing) | -5.89M | -4.54M | -4.86M | -5.42M | -5.11M | 1.24M | -4.23M | -2.45M | -2.3M | -282.76K | -334.03K | -1.44M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.20 | -2.30 | -9.10 | -61.71 | -3.18 | 0.56 | -17.02 | -30.23 | -31.27 | -432.91 | -29.76 | -46.17 |
| EPS Growth % | 93.71% | -510.71% | 46.53% | -104.14% | 89.83% | 100.13% | 42.81% | 34.53% | 41.91% | -5478.74% | - | - |
| EPS (Basic) | -0.20 | -2.30 | -9.10 | -61.71 | -3.18 | 0.56 | -17.02 | -30.23 | -31.27 | -432.91 | -29.76 | -46.17 |
| Diluted Shares Outstanding | 28.76M | 4.23M | 1.26M | 488.08K | 171.38K | 120.79K | 24.84K | 8.1K | 7.35K | 7.35K | 7.35K | 7.35K |
| Basic Shares Outstanding | 28.76M | 4.23M | 1.26M | 488.08K | 171.38K | 120.79K | 24.84K | 8.1K | 7.35K | 7.35K | 7.35K | 7.35K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |